A-type lamin-linked lipodystrophies

Novartis Foundation Symposium

Volumn 264, Issue , 2005, Pages 166-177

  Vigouroux, Corinne ^a   Capeau, Jacqueline ^a  

^a HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIN A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

GENETIC LINKAGE; GENETICS; HUMAN; LIPODYSTROPHY; METABOLISM; MUTATION; REVIEW;

HUMANS; LAMIN TYPE A; LINKAGE (GENETICS); LIPODYSTROPHY; MUTATION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS;

EID: 16244388206     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (42)

1. Agarwal AK, Arioglu E, De Almeida S et al 2002 AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet 31:21-23
2. Agarwal AK, Fryns JP, Auchus RJ, Garg A 2003 Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum Mol Genet 12:1995-2001
3. Behrens GM, Lloyd D, SchmidtHHet al 2000 Lessons from lipodystrophy: LMNA, encoding lamin A/C, in HIV therapy-associated lipodystrophy. AIDS 14:1854-1855
4. Cao H, Hegele RA 2000 Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 9: 109-112
5. Capanni C, Cenni V, Mattioli E et al 2003 Failure of lamin A/C to functionally assemble in R482L mutated familial partial lipodystrophy fibroblasts: altered intermolecular interaction with emerin and implications for gene transcription. Exp Cell Res 291:122-134
6. Caron M, Auclair M, Vigouroux C et al 2001 The HIV protease inhibitor indinavir impairs sterol regulatory element- binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance. Diabetes 50:1378-1388
7. Caron M, Auclair M, Sterlingot H et al 2003 Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation. AIDS 17:2437-2444
8. Caux F, Dubosclard E, Lascols O et al 2003 A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy. J Clin Endocrinol Metab 88:1006-1013
9. Chen D, Misra A, Garg A 2002 Lipodystrophy in human immunodefficiency virus-infected patients. J Clin Endocrinol Metab 87:4845-4485
10. Dhe-Paganon S, Werner ED, Chi YI, Shoelson SE 2002 Structure of the globular tail of nuclear lamin. J Biol Chem 277:17381-17384
11. Chen L, Lee L, Kudlow BA et al 2003 LMNA mutations in atypical Werner's syndrome. Lancet 362:440-445
12. Favreau C, Dubosclard E, Ostlund C et al 2003 Expression of lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with Dunnigan-type partial lipodystrophy and Emery-Dreifuss muscular dystrophy. Exp Cell Res 282:14-23
13. Garg A 2000a Lipodystrophies. Am J Med 108:143-152
14. Garg A 2000b Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab 85:1776-1782
15. Garg A, Peshock RM, Fleckenstein JL 1999 Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab 84:170-174
16. Garg A, Vinaitheerthan M, Weatherall PT, Bowcock AM 2001 Phenotypic heterogeneity in patients with familial partial lipodystrophy (Dunnigan variety) related to the site of missense mutations in lamin A/C gene. J Clin Endocrinol Metab 86:59-65
17. Garg A, Speckman RA, Bowcock AM 2002 Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene. Am J Med 112:549-555
18. Hegele RA 2003 Monogenic forms of insulin resistance: apertures that expose the common metabolic syndrome. Trends Endocrinol Metab 14:371-377
19. Hegele RA, Cao H, Anderson CM et al 2000 Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy. J Clin Endocrinol Metab 85:3431-3435
20. Hegele RA, Huff MW, Young TK 2001 Common genomic variation in LMNA modulates indexes of obesity in Inuit. J Clin Endocrinol Metab 86:2747-2751
21. Hegele RA, Kraw ME, Ban MR, Miskie BA, Huff MW, Cao H 2003 Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophy. Arterioscler Thromb Vasc Biol 23:111-116
22. Krimm I, Ostlund C, Gilquin B et al 2002 The Ig-like structure of the C-terminal domain of lamin A/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy. Structure (Camb) 10:811-823
23. Lloyd DJ, Trembath RC, Shackleton S 2002 A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum Mol Genet 2002 11:769-777
24. Magré J, Delépine M, Khallouf E et al 2001 Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 28:365-370
25. Magré J, Delepine M, Van Maldergem L et al 2003 Prevalence of mutations in AGPAT2 among human lipodystrophies. Diabetes 52:1573-1578
26. Novelli G, d'Apice MR 2003 The strange case of the "lumper" lamin A/C gene and human premature ageing. Trends Mol Med 9:370-375
27. Oral EA, Simha V, Ruiz E et al 2002 Leptin-replacement therapy for lipodystrophy. N Engl J Med 346:570-578
28. Östlund C, Bonne G, Schwartz K et al 2001 Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy. J Cell Sci 114:4435-4445
29. Owen KR, Donohoe M, Ellard S, Hattersley AT 2003 Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene. Diabet Med 20:823-827
30. Rajala MW, Scherer PE 2003 Minireview: the adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144:3765-3773
31. Reitman ML, Arioglu E, Gavrilova O et al 2000 Lipoatrophy revisited. Trends Endocrinol Metab 11:410-416
32. Schmidt HH, Genschel J, Baier P et al 2001 Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene. J Clin Endocrinol Metab 86: 2289-2295
33. Simha V, Agarwal AK, Oral EA et al 2003 Genetic and phenotypic heterogeneity in patients with mandibuloacral dysplasia-associated lipodystrophy. J Clin Endocrinol Metab 88:2821-2824
34. Shackleton S, Lloyd DJ, Jackson SN et al 2000 LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet 24:153-156
35. Speckman RA, Garg A, Du F et al 2000 Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Hum Genet 66:1192-1198
36. Stierle V, Couprie J, Ostlund C et al 2003 The carboxyl-terminal region common to lamins A and C contains a DNA binding domain. Biochemistry 42:4819-4828
37. van der Kooi AJ, Bonne G, Eymard B et al 2002 Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy. Neurology 59:620-623
38. Vantyghem MC, Pigny P, Maurage CA et al 2004 Patients with familial partial lipodystrophy of the dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities. J Clin Endocrinol Metab, in press
39. Vigouroux C, Magré J, Vantyghem MC et al 2000 Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes 49:1958-1962
40. Vigouroux C, Auclair M, Dubosclard E et al 2001 Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in lamin A/C gene. J Cell Sci 114:4459-4468
41. Vigouroux C, Caux F, Capeau J et al 2003 LMNA mutations in atypical Werner's syndrome. Lancet 362:1585
42. Wolford JK, Hanson RL, Bogardus C et al 2001 Analysis of the lamin A/C gene as a candidate for type II diabetes susceptibility in Pima Indians. Diabetologia 44:779-782